Extend your funding runway: How to maintain capital efficiency in an improving market

As we enter a new cycle of increased investment activity with rising IPOs and continued "mega-rounds," biotech companies face a critical challenge: How to maintain fiscal discipline when funding becomes more accessible. This webinar addresses the paradox many companies experienced during the 2020-2021 funding boom – raising capital but subsequently losing efficiency in deployment. We'll provide actionable approaches for maintaining strategic discipline even as market conditions improve, ensuring sustainable growth and avoiding the common pitfalls of resource misallocation during funding upswings

Learning objectives:

• Implement capital-efficient development strategies tailored to 2026's funding environment, including prioritization frameworks and potential geographic diversification
• Design streamlined development pathways that optimize the balance between accelerated development and prudent spending, maintaining focus on critical value inflection points
• Evaluate and pursue alternative operational models including strategic outsourcing, shared resource arrangements, and virtual team structures that minimize fixed costs while maximizing development capabilities

Speakers: